Ming Liu

Ming Liu

Joint Department of Biomedical Engineering, North Carolina State University & University of North Carolina at Chapel Hill

Affiliated withNorth Carolina State University & University of North Carolina at Chapel HillBeijing Hospital, National Center of Gerontologybeijing hospital

+3

Research Area

Biography

Deputy director of Urology administration of Beijing hospital, director of English teaching and research section of Education Department of Beijing Hospital. Member of International Exchange Committee of Chinese society of Urology, member of medical laser and equipment professional committee, member of oncology group of Beijing Society of Urology, member of Urology branch of Beijing Medical Award Foundation, young member of Urology branch of male genitourinary cancer Professional Committee of anti cancer association, young member of Urology branch of Chinese Medical Doctor Association, young member of Chinese Geriatric Society Committee member. He has studied in King's College Hospital in London, Duke University Hospital in the United States and University of Toronto Hospital in Canada. Mainly engaged in the diagnosis and treatment of urogenital system tumors (including prostate cancer, renal cancer, bladder cancer, etc.) and prostate hyperplasia in the elderly. He is especially good at the comprehensive diagnosis and treatment of prostate cancer. He participated in the establishment of the prostate cancer expert cooperation group of Beijing hospital and presided over the multidisciplinary case seminar of prostate cancer in Beijing Hospital

JoVE Journal Publications

ArticleTotal : 6
Year
Engineering Platform and Experimental Protocol for Design and Evaluation of a Neurally-controlled Powered Transfemoral Prosthesis
Publication title

Cited by 15

2014
2018
2019
2020
2023

Other Publications

Article
Year
Bile duct injury and bile leakage in laparoscopic cholecystectomy.

The British journal of surgery| PubMed ID: 8298933

1993
Gemcitabine versus the combination of cisplatin and etoposide in patients with inoperable non-small-cell lung cancer in a phase II randomized study.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology| PubMed ID: 9164223

1997
2000
2003
[Evaluation for clinical staging parameters of prostate neoplasm].

Zhonghua nan ke xue = National journal of andrology| PubMed ID: 12749126

2003
[Diagnosis and treatment of early prostate cancer].

Zhonghua nan ke xue = National journal of andrology| PubMed ID: 16209214

2005
2006
2007
2008
2008
2008
[Transperitoneal laparoscopic adrenalectomy: surgical approach and outcome].

Zhonghua wai ke za zhi [Chinese journal of surgery]| PubMed ID: 19134375

2008
2011
Diffusion tensor imaging of prostate at 3.0 Tesla.

Acta radiologica (Stockholm, Sweden : 1987)| PubMed ID: 21586608

2011
2011
2011
2012
[Association of prostate cancer with PDLIM5, SLC22A3 and NKX3-1 in Chinese men].

Zhonghua nan ke xue = National journal of andrology| PubMed ID: 22741436

2012
Association of six susceptibility Loci with prostate cancer in northern chinese men.

Asian Pacific journal of cancer prevention : APJCP| PubMed ID: 23464444

2012
2013
Susceptibility Loci associations with prostate cancer risk in northern chinese men.

Asian Pacific journal of cancer prevention : APJCP| PubMed ID: 23803082

2013
Low-power circuits for the bidirectional wireless monitoring system of the orthopedic implants.

IEEE transactions on biomedical circuits and systems| PubMed ID: 23853291

2009
[Association of TET2, LMTK2 and FAM84B gene expression with prostate cancer risk in Chinese patients].

Zhonghua zhong liu za zhi [Chinese journal of oncology]| PubMed ID: 23985253

2013
2013
Association of 8 loci on chromosome 8q24 with prostate carcinoma risk in northern Chinese men.

Asian Pacific journal of cancer prevention : APJCP| PubMed ID: 24377597

2014
2014
2014
The Cumulative Effect of Gene-Gene and Gene-Environment Interactions on the Risk of Prostate Cancer in Chinese Men.

International journal of environmental research and public health| PubMed ID: 26828504

2016
2016
2017
2018
2018
The Urinary Sarcosine/Creatinine Ratio is a Potential Diagnostic and Prognostic Marker in Prostate Cancer.

Medical science monitor : international medical journal of experimental and clinical research| PubMed ID: 29741162

2018
2018
2018
2018
2019
Comparison of radical prostatectomy versus conservative treatment in localized prostate cancer: systematic review and meta-analysis.

Journal of B.U.ON. : official journal of the Balkan Union of Oncology| PubMed ID: 30941976

2019
2019
2019
2019
2019
2019
2019
2019
2019
2020
2020
Diagnosis and Grading of Prostate Cancer by Relaxation Maps From Synthetic MRI.

Journal of magnetic resonance imaging : JMRI| PubMed ID: 32027071

2020
2020
2020
Comprehensive Analysis Identifying Wnt Ligands Gene Family for Biochemical Recurrence in Prostate Adenocarcinoma and Construction of a Nomogram.

Journal of computational biology : a journal of computational molecular cell biology| PubMed ID: 32298604

2020
2020
2020
Surgery in renal cell carcinoma patients with lung and bronchus metastasis.

Annals of translational medicine| PubMed ID: 32355849

2020
2019
A hepatocyte differentiation model reveals two subtypes of liver cancer with different oncofetal properties and therapeutic targets.

Proceedings of the National Academy of Sciences of the United States of America| PubMed ID: 32123069

2020
2020
2021
2021
2021
2021
2021
2021
2022
Identification of Subtypes of HCC Using Bioinformatics and the Hepatocyte Differentiation Model.

Methods in molecular biology (Clifton, N.J.)| PubMed ID: 36125724

2022
2022
2022